Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 182

1.

Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis.

De Stefano N, Stromillo ML, Giorgio A, Bartolozzi ML, Battaglini M, Baldini M, Portaccio E, Amato MP, Sormani MP.

J Neurol Neurosurg Psychiatry. 2015 Apr 22. pii: jnnp-2014-309903. doi: 10.1136/jnnp-2014-309903. [Epub ahead of print]

2.

Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.

Amato MP, Portaccio E.

CNS Drugs. 2015 Mar;29(3):207-20. doi: 10.1007/s40263-015-0238-y.

PMID:
25773609
3.

Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial.

Mancardi GL, Sormani MP, Gualandi F, Saiz A, Carreras E, Merelli E, Donelli A, Lugaresi A, Di Bartolomeo P, Rottoli MR, Rambaldi A, Amato MP, Massacesi L, Di Gioia M, Vuolo L, Currò D, Roccatagliata L, Filippi M, Aguglia U, Iacopino P, Farge D, Saccardi R; ASTIMS Haemato-Neurological Collaborative Group, On behalf of the Autoimmune Disease Working Party (ADWP) of the European Group for Blood and Marrow Transplantation (EBMT); ASTIMS Haemato-Neurological Collaborative Group On behalf of the Autoimmune Disease Working Party ADWP of the European Group for Blood and Marrow Transplantation EBMT.

Neurology. 2015 Mar 10;84(10):981-8. doi: 10.1212/WNL.0000000000001329. Epub 2015 Feb 11.

PMID:
25672923
4.

Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis.

Rocca MA, Amato MP, De Stefano N, Enzinger C, Geurts JJ, Penner IK, Rovira A, Sumowski JF, Valsasina P, Filippi M; MAGNIMS Study Group.

Lancet Neurol. 2015 Mar;14(3):302-17. doi: 10.1016/S1474-4422(14)70250-9. Epub 2015 Feb 4. Review.

PMID:
25662900
5.

Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures.

Giorgio A, Stromillo ML, De Leucio A, Rossi F, Brandes I, Hakiki B, Portaccio E, Amato MP, De Stefano N.

J Neurosci. 2015 Jan 14;35(2):550-8. doi: 10.1523/JNEUROSCI.2557-14.2015.

PMID:
25589750
6.

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.

Kalincik T, Jokubaitis V, Izquierdo G, Duquette P, Girard M, Grammond P, Lugaresi A, Oreja-Guevara C, Bergamaschi R, Hupperts R, Grand'Maison F, Pucci E, Van Pesch V, Boz C, Iuliano G, Fernandez-Bolanos R, Flechter S, Spitaleri D, Cristiano E, Verheul F, Lechner-Scott J, Amato MP, Cabrera-Gomez JA, Saladino ML, Slee M, Moore F, Gray O, Paine M, Barnett M, Havrdova E, Horakova D, Spelman T, Trojano M, Butzkueven H; On behalf of the MSBase Study Group; On behalf of the MSBase Study Group.

Mult Scler. 2014 Dec 5. pii: 1352458514559865. [Epub ahead of print]

PMID:
25480857
7.

Cognitive impairment in paediatric multiple sclerosis patients is not related to cortical lesions.

Rocca MA, De Meo E, Amato MP, Copetti M, Moiola L, Ghezzi A, Veggiotti P, Capra R, Fiorino A, Pippolo L, Pera MC, Falini A, Comi G, Filippi M.

Mult Scler. 2014 Nov 12. pii: 1352458514557303. [Epub ahead of print]

PMID:
25392332
8.

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.

Spelman T, Gray O, Trojano M, Petersen T, Izquierdo G, Lugaresi A, Hupperts R, Bergamaschi R, Duquette P, Grammond P, Giuliani G, Boz C, Verheul F, Oreja-Guevara C, Barnett M, Grand'Maison F, Edite Rio M, Lechner-Scott J, Van Pesch V, Fernandez Bolanos R, Flechter S, Den Braber-Moerland L, Iuliano G, Amato MP, Slee M, Cristiano E, Saladino ML, Paine M, Vella N, Kasa K, Deri N, Herbert J, Moore F, Petkovska-Boskova T, Alroughani R, Savino A, Shaw C, Vucic S, Santiago V, Bacile EA, Skromne E, Poehlau D, Cabrera-Gomez JA, Lucas R, Butzkueven H.

Ann Neurol. 2014 Dec;76(6):880-90. doi: 10.1002/ana.24287. Epub 2014 Oct 20.

PMID:
25283272
9.

Neuropsychological features in childhood and juvenile multiple sclerosis: five-year follow-up.

Amato MP, Goretti B, Ghezzi A, Hakiki B, Niccolai C, Lori S, Moiola L, Falautano M, Viterbo RG, Patti F, Cilia S, Pozzilli C, Bianchi V, Roscio M, Martinelli V, Comi G, Portaccio E, Trojano M; MS Study Group of the Italian Neurological Society.

Neurology. 2014 Oct 14;83(16):1432-8. doi: 10.1212/WNL.0000000000000885. Epub 2014 Sep 12.

PMID:
25217060
10.

The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population.

Goretti B, Niccolai C, Hakiki B, Sturchio A, Falautano M, Minacapelli E, Martinelli V, Incerti C, Nocentini U, Murgia M, Fenu G, Cocco E, Marrosu MG, Garofalo E, Ambra FI, Maddestra M, Consalvo M, Viterbo RG, Trojano M, Losignore NA, Zimatore GB, Pietrolongo E, Lugaresi A, Langdon D, Portaccio E, Amato MP.

BMC Neurol. 2014 Sep 10;14:171. doi: 10.1186/s12883-014-0171-6.

11.

Assessing executive function with the D-KEFS sorting test: normative data for a sample of the Italian adult population.

Mattioli F, Stampatori C, Bellomi F, Scarpazza C, Galli P, Guarneri C, Corso B, Montomoli C, Niccolai C, Goretti B, Amato MP, Riboni E, Tomasina CD, Falautano M, Capra R.

Neurol Sci. 2014 Dec;35(12):1895-902. doi: 10.1007/s10072-014-1857-7. Epub 2014 Jul 6.

PMID:
24998015
12.

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.

Pecori C, Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pastò L, Razzolini L, Sturchio A, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, Mancardi GL, Solaro C, Totaro R, Tola MR, De Luca G, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

BMC Neurol. 2014 May 26;14:114. doi: 10.1186/1471-2377-14-114.

13.

Risk of relapse phenotype recurrence in multiple sclerosis.

Kalincik T, Buzzard K, Jokubaitis V, Trojano M, Duquette P, Izquierdo G, Girard M, Lugaresi A, Grammond P, Grand'Maison F, Oreja-Guevara C, Boz C, Hupperts R, Petersen T, Giuliani G, Iuliano G, Lechner-Scott J, Barnett M, Bergamaschi R, Van Pesch V, Amato MP, van Munster E, Fernandez-Bolanos R, Verheul F, Fiol M, Cristiano E, Slee M, Rio ME, Spitaleri D, Alroughani R, Gray O, Saladino ML, Flechter S, Herbert J, Cabrera-Gomez JA, Vella N, Paine M, Shaw C, Moore F, Vucic S, Savino A, Singhal B, Petkovska-Boskova T, Parratt J, Sirbu CA, Rozsa C, Liew D, Butzkueven H; MSBase Study Group.

Mult Scler. 2014 Oct;20(11):1511-22. doi: 10.1177/1352458514528762. Epub 2014 Apr 28.

PMID:
24777276
14.

MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients.

Serana F, Imberti L, Amato MP, Comi G, Gasperini C, Ghezzi A, Martinelli V, Provinciali L, Rottoli MR, Sotgiu S, Stecchi S, Vecchio M, Zaffaroni M, Cordioli C, Capra R.

PLoS One. 2014 Apr 14;9(4):e94794. doi: 10.1371/journal.pone.0094794. eCollection 2014.

15.

Emotional and neutral verbal memory impairment in Multiple Sclerosis.

Iaffaldano P, Viterbo RG, Goretti B, Portaccio E, Amato MP, Trojano M.

J Neurol Sci. 2014 Jun 15;341(1-2):28-31. doi: 10.1016/j.jns.2014.03.038. Epub 2014 Mar 26.

PMID:
24713509
16.

Posterior brain damage and cognitive impairment in pediatric multiple sclerosis.

Rocca MA, Absinta M, Amato MP, Moiola L, Ghezzi A, Veggiotti P, Capra R, Portaccio E, Fiorino A, Pippolo L, Pera MC, Horsfield MA, Falini A, Comi G, Filippi M.

Neurology. 2014 Apr 15;82(15):1314-21. doi: 10.1212/WNL.0000000000000309. Epub 2014 Mar 19.

PMID:
24647027
17.

Radiologically isolated syndrome: 5-year risk for an initial clinical event.

Okuda DT, Siva A, Kantarci O, Inglese M, Katz I, Tutuncu M, Keegan BM, Donlon S, Hua le H, Vidal-Jordana A, Montalban X, Rovira A, Tintoré M, Amato MP, Brochet B, de Seze J, Brassat D, Vermersch P, De Stefano N, Sormani MP, Pelletier D, Lebrun C; Radiologically Isolated Syndrome Consortium (RISC); Club Francophone de la Sclérose en Plaques (CFSEP).

PLoS One. 2014 Mar 5;9(3):e90509. doi: 10.1371/journal.pone.0090509. eCollection 2014.

18.

Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosis.

Rocca MA, Valsasina P, Absinta M, Moiola L, Ghezzi A, Veggiotti P, Amato MP, Horsfield MA, Falini A, Comi G, Filippi M.

Hum Brain Mapp. 2014 Aug;35(8):4180-92. doi: 10.1002/hbm.22469. Epub 2014 Feb 7.

PMID:
24510680
19.

Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.

Portaccio E, Ghezzi A, Hakiki B, Sturchio A, Martinelli V, Moiola L, Patti F, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, De Luca G, Paolicelli D, Marrosu MG, Comi G, Trojano M, Amato MP; MS Study Group of the Italian Neurological Society.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):845-50. doi: 10.1136/jnnp-2013-306054. Epub 2014 Jan 8.

PMID:
24403285
20.

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.

Bertolotto A, Capobianco M, Amato MP, Capello E, Capra R, Centonze D, Di Ioia M, Gallo A, Grimaldi L, Imberti L, Lugaresi A, Mancinelli C, Marrosu MG, Moiola L, Montanari E, Romano S, Musu L, Paolicelli D, Patti F, Pozzilli C, Rossi S, Salvetti M, Tedeschi G, Tola MR, Trojano M, Zaffaroni M, Malucchi S; Italian Multiple Sclerosis Study group.

Neurol Sci. 2014 Feb;35(2):307-16. doi: 10.1007/s10072-013-1616-1. Epub 2013 Dec 29. Erratum in: Neurol Sci. 2014 Oct;35(10):1645-6. Troiano, Maria [corrected to Trojano, Maria].

PMID:
24374787
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk